Log inSign up
user avatar
Immutep
@Immutep
A late-stage clinical biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease. (ASX: IMM, NASDAQ: IMMP)
Global
immutep.com
Joined February 2011
1,713
Following
1,950
Followers

@Immutep hasn’t posted

When they do, their posts will show up here.